Xspray Pharma
Xspray Pharma: Adding capital to the war chest (Redeye)
2019-12-06 09:00
Xspray has carried out a directed share issue which will generate approximately SEK 122 million before transaction fees. The capital puts Xspray in a stronger position as they move closer to market launch with HyNap-Dasa.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se